Cargando…

Major malformations risk following early pregnancy exposure to metformin: a systematic review and meta-analysis

Metformin is considered as first-line treatment for type 2 diabetes and an effective treatment for polycystic ovary syndrome (PCOS). However, evidence regarding its safety in pregnancy is limited. We conducted a systematic review and meta-analysis of major congenital malformations (MCMs) risk after...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abolhassani, Nazanin, Winterfeld, Ursula, Kaplan, Yusuf C, Jaques, Cécile, Minder Wyssmann, Beatrice, Del Giovane, Cinzia, Panchaud, Alice
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2023
Materias:	Epidemiology/Health services research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9890805/ https://www.ncbi.nlm.nih.gov/pubmed/36720508 http://dx.doi.org/10.1136/bmjdrc-2022-002919

Ejemplares similares

Mental health status of pregnant and breastfeeding women during the COVID‐19 pandemic—A multinational cross‐sectional study
por: Ceulemans, Michael, et al.
Publicado: (2021)

Antidepressant use during pregnancy and the risk of major congenital malformations in a cohort of depressed pregnant women: an updated analysis of the Quebec Pregnancy Cohort
por: Bérard, Anick, et al.
Publicado: (2017)

Association of vitamin B(12) deficiency in people with type 2 diabetes on metformin and without metformin: a multicenter study, Karachi, Pakistan
por: Miyan, Zahid, et al.
Publicado: (2020)

Metformin and breast and gynecological cancer risk among women with diabetes
por: Soffer, Diana, et al.
Publicado: (2015)

Metformin Use in Prediabetes Among U.S. Adults, 2005–2012
por: Tseng, Eva, et al.
Publicado: (2017)

Health Beliefs Associated With Metformin Use Among Insured Adults With Prediabetes
por: McEwen, Laura N., et al.
Publicado: (2022)

Incidence of Bladder Cancer in Patients With Type 2 Diabetes Treated With Metformin or Sulfonylureas
por: Mamtani, Ronac, et al.
Publicado: (2014)

Risk of Anemia With Metformin Use in Type 2 Diabetes: A MASTERMIND Study
por: Donnelly, Louise A., et al.
Publicado: (2020)

Potential Impact of Prescribing Metformin According to eGFR Rather Than Serum Creatinine
por: Tuot, Delphine S., et al.
Publicado: (2015)

Association between metformin and neurodegenerative diseases of observational studies: systematic review and meta-analysis
por: Ping, Fan, et al.
Publicado: (2020)

Hospitalization for Lactic Acidosis Among Patients With Reduced Kidney Function Treated With Metformin or Sulfonylureas
por: Chu, Patricia Y., et al.
Publicado: (2020)

Comment to “Pregnancy and COVID-19, focus on vaccine and pharmacological treatment”
por: Ceulemans, Michael, et al.
Publicado: (2022)

Impact of glycemic traits, type 2 diabetes and metformin use on breast and prostate cancer risk: a Mendelian randomization study
por: Au Yeung, Shiu Lun, et al.
Publicado: (2019)

Use of metformin following a population-level intervention to encourage people with pre-diabetes to enroll in the National Diabetes Prevention Program
por: Hurst, Thomas E, et al.
Publicado: (2021)

Risk of congenital malformation following first trimester mRNA COVID-19 vaccine exposure in pregnancy: the COVI-PREG prospective cohort
por: Favre, Guillaume, et al.
Publicado: (2023)

Comparative effect of metformin versus sulfonylureas with dementia and Parkinson’s disease risk in US patients over 50 with type 2 diabetes mellitus
por: Newby, Danielle, et al.
Publicado: (2022)

Current Data on COVID-19 mRNA-Vaccine Safety during Pregnancy Might Be Subject to Selection Bias. Reply to Stroobandt, S.; Stroobandt, R. Data of the COVID-19 mRNA-Vaccine V-Safe Surveillance System and Pregnancy Registry Reveals Poor Embryonic and Second Trimester Fetal Survival Rate. Comment on “Stuckelberger et al. SARS-CoV-2 Vaccine Willingness among Pregnant and Breastfeeding Women during the First Pandemic Wave: A Cross-Sectional Study in Switzerland. Viruses 2021, 13, 1199”
por: Stuckelberger, Sarah, et al.
Publicado: (2021)

Development and validation of a life expectancy estimator for multimorbid older adults: a cohort study protocol
por: Gastens, Viktoria, et al.
Publicado: (2021)

Lifestyle and Metformin Interventions Have a Durable Effect to Lower CRP and tPA Levels in the Diabetes Prevention Program Except in Those Who Develop Diabetes
por: Goldberg, Ronald B., et al.
Publicado: (2014)

Glucagon-like peptide 1 agonists for treatment of patients with type 2 diabetes who fail metformin monotherapy: systematic review and meta-analysis of economic evaluation studies
por: Bagepally, Bhavani Shankara, et al.
Publicado: (2020)

Cardiovascular and renal outcomes among patients with type 2 diabetes using SGLT2 inhibitors added to metformin: a population-based cohort study from the UK
por: Gonzalez Perez, Antonio, et al.
Publicado: (2023)

Trends in diabetes in pregnancy in Sweden 1998–2012
por: Fadl, Helena E, et al.
Publicado: (2016)

Antidiabetic medication use during pregnancy: an international utilization study
por: Cesta, Carolyn E, et al.
Publicado: (2019)

Exploring abnormal glucose metabolism in pregnancy among Australian Chinese migrants
por: Li, Ling-Jun, et al.
Publicado: (2020)

Use of Prescribed Drugs to Treat Chronic Diseases during Pregnancy in Outpatient Care in Switzerland between 2014 and 2018: Descriptive Analysis of Swiss Health Care Claims Data
por: Gerbier, Eva, et al.
Publicado: (2022)

Diabetes mellitus is associated with a higher risk for major depressive disorder in women than in men
por: Deischinger, Carola, et al.
Publicado: (2020)

Metabolomics Reveals Broad-Scale Metabolic Perturbations in Hyperglycemic Mothers During Pregnancy
por: Scholtens, Denise M., et al.
Publicado: (2014)

‘Turning the tide’ on hyperglycemia in pregnancy: insights from multiscale dynamic simulation modeling
por: Freebairn, Louise, et al.
Publicado: (2020)

Comparing IADPSG and NICE Diagnostic Criteria for GDM in Predicting Adverse Pregnancy Outcomes
por: He, Yuanying, et al.
Publicado: (2022)

Antidiabetic Medication Utilisation before and during Pregnancy in Switzerland between 2012 and 2019: An Administrative Claim Database from the MAMA Cohort
por: Gerbier, Eva, et al.
Publicado: (2023)

Maternal glycemic parameters and adverse pregnancy outcomes among high-risk pregnant women
por: Zheng, Yanwei, et al.
Publicado: (2019)

Timing of delivery in women with pre-pregnancy diabetes mellitus: a population-based study
por: Brown, Meghan, et al.
Publicado: (2019)

Pregravid Liver Enzyme Levels and Risk of Gestational Diabetes Mellitus During a Subsequent Pregnancy
por: Sridhar, Sneha B., et al.
Publicado: (2014)

Preventing diabetes after pregnancy with gestational diabetes in a Cree community: an inductive thematic analysis
por: Pace, Romina, et al.
Publicado: (2020)

What factors explain the much higher diabetes prevalence in Russia compared with Norway? Major sex differences in the contribution of adiposity
por: Iakunchykova, Olena, et al.
Publicado: (2021)

Untreated Mild Hyperglycemia During Pregnancy and Anthropometric Measures of Obesity in Offspring at Age 5–7 Years
por: Thaware, Parag K., et al.
Publicado: (2015)

Core outcome set for diabetes after pregnancy prevention across the life span: international Delphi study
por: Wu, Nancy, et al.
Publicado: (2020)

Development and validation of an early pregnancy risk score for the prediction of gestational diabetes mellitus in Chinese pregnant women
por: Gao, Si, et al.
Publicado: (2020)

New index of social deprivation during pregnancy: results from a national study in France
por: Opatowski, Marion, et al.
Publicado: (2016)

Insulin pricing and other major diabetes-related concerns in the USA: a study of 46 407 tweets between 2017 and 2019
por: Ahne, Adrian, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_kef055n5mntcpt4nf0e05gpvg7